Terminated OBSERVATIONAL NCT00195897

Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)

Early Assessment of Anthracycline-induced Cardiotoxicity: Usefulness of Biochemical Markers and Ventricular Function Assessment.

Sponsor: Centre Henri Becquerel

Conditions Heart Failure, Congestive Lymphoma

Updated 7 times since 2017 Last updated: Aug 19, 2016 Started: Jan 31, 2006 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No patients; only 6 enrolled after 2 years

This observational or N/A phase trial investigates Heart Failure, Congestive and Lymphoma and is currently terminated or withdrawn. Centre Henri Becquerel leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Terminated
Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Terminated NA

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Henri Becquerel
Ligue contre le cancer, France

Data source: Centre Henri Becquerel

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rouen, France